-
1
-
-
0022971804
-
Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas
-
Ørskov, C., Holst, J.J., Knuhtsen, S., Baldissera, F.G., Poulsen, S.S., and Nielsen, O.V., 1986, Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas. Endocrinology 119: 1467-1475
-
(1986)
Endocrinology
, vol.119
, pp. 1467-1475
-
-
Ørskov, C.1
Holst, J.J.2
Knuhtsen, S.3
Baldissera, F.G.4
Poulsen, S.S.5
Nielsen, O.V.6
-
2
-
-
0023008693
-
Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing
-
Mojsov, S., Heinrich, G., Wilson, I.B., Ravazzola, M., Orci, L., and Habener, J.F., 1986, Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. J Biol Chem 261: 11880-11889
-
(1986)
J Biol Chem
, vol.261
, pp. 11880-11889
-
-
Mojsov, S.1
Heinrich, G.2
Wilson, I.B.3
Ravazzola, M.4
Orci, L.5
Habener, J.F.6
-
3
-
-
0027227370
-
Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: Acute post-prandial and 24-h secretion patterns
-
Elliott, R.M., Morgan, L.M., Tredger, J.A., Deacon, S., Wright, J., and Marks, V., 1993, Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns. Endocrinology 138: 159-166
-
(1993)
Endocrinology
, vol.138
, pp. 159-166
-
-
Elliott, R.M.1
Morgan, L.M.2
Tredger, J.A.3
Deacon, S.4
Wright, J.5
Marks, V.6
-
4
-
-
0026775150
-
Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1
-
Thorens, B., 1992, Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci U S A 89: 8641-8645
-
(1992)
Proc Natl Acad Sci U S A
, vol.89
, pp. 8641-8645
-
-
Thorens, B.1
-
5
-
-
0028198851
-
Structure-activity studies og glucagon-like peptide-1
-
Adelhorst, K., Hedegaard, B.B., Knudsen, L.B., and Kirk, O., 1994, Structure-activity studies og glucagon-like peptide-1. J Biol Chem 269: 6275-6278
-
(1994)
J Biol Chem
, vol.269
, pp. 6275-6278
-
-
Adelhorst, K.1
Hedegaard, B.B.2
Knudsen, L.B.3
Kirk, O.4
-
6
-
-
0023758530
-
Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107)amide] on endocrine secretion from pig pancreas, antrum and non-antral stomach
-
Ørskov, C., Holst, J.J., and Nielsen, O.V., 1988, Effect of truncated glucagon-like peptide-1 [proglucagon-(78-107)amide] on endocrine secretion from pig pancreas, antrum and non-antral stomach. Endocrinology 123: 2009-2013
-
(1988)
Endocrinology
, vol.123
, pp. 2009-2013
-
-
Ørskov, C.1
Holst, J.J.2
Nielsen, O.V.3
-
7
-
-
0024515406
-
Glucagon-like peptide I (7-37) actions on the endocrine pancreas
-
Weir, G.C., Mojsov, S., Hendrick, G.K., and Habener, J.F., 1989, Glucagon-like peptide I (7-37) actions on the endocrine pancreas. Diabetes 38: 338-342
-
(1989)
Diabetes
, vol.38
, pp. 338-342
-
-
Weir, G.C.1
Mojsov, S.2
Hendrick, G.K.3
Habener, J.F.4
-
8
-
-
0344357096
-
Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in rat islet cell line
-
Drucker, D.J., Philippe, J., Mojsov, S., Chick, W.L., and Habener, J.F., 1987, Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in rat islet cell line. Proc Natl Acad Sci USA 84: 3434-3438
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 3434-3438
-
-
Drucker, D.J.1
Philippe, J.2
Mojsov, S.3
Chick, W.L.4
Habener, J.F.5
-
9
-
-
0026535588
-
Insulinotropic hormone glucagon-like peptide-I (7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma βTC-1 cells
-
Fehmann, H.C., and Habener, J.F., 1992, Insulinotropic hormone glucagon-like peptide-I (7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma βTC-1 cells. Endocrinology 130: 159-166
-
(1992)
Endocrinology
, vol.130
, pp. 159-166
-
-
Fehmann, H.C.1
Habener, J.F.2
-
10
-
-
0027473729
-
Pancreatic beta cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7-36)
-
Holz, G.G., Kühtreiber, W.M., and Habener, J.F., 1993, Pancreatic beta cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1 (7-36). Nature 361: 362-365
-
(1993)
Nature
, vol.361
, pp. 362-365
-
-
Holz, G.G.1
Kühtreiber, W.M.2
Habener, J.F.3
-
11
-
-
0031820844
-
Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance
-
Byrne, M.M., Gliem, K., Wank, U., Arnold, R., Katschinski, M., Polonsky, K.S., and Göke, B., 1998, Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance. Diabetes 47: 1259-1265
-
(1998)
Diabetes
, vol.47
, pp. 1259-1265
-
-
Byrne, M.M.1
Gliem, K.2
Wank, U.3
Arnold, R.4
Katschinski, M.5
Polonsky, K.S.6
Göke, B.7
-
12
-
-
0032908809
-
Initiation of increased pancreatic islet growth in young normoglycemic mice (Umeå +/?)
-
Edvell, A., and Lindström, P., 1999 Initiation of increased pancreatic islet growth in young normoglycemic mice (Umeå +/?). Endocrinology 140: 778-783
-
(1999)
Endocrinology
, vol.140
, pp. 778-783
-
-
Edvell, A.1
Lindström, P.2
-
13
-
-
0001592657
-
Activation of GLP-1 receptor signalling is coupled to inhibition of apoptosis in heterologous cell types
-
abstract
-
Hansotia, T., Yusta, B., and Drucker, D.J., 2001, Activation of GLP-1 receptor signalling is coupled to inhibition of apoptosis in heterologous cell types. Diabetes 50 (Suppl 2): A350 (abstract)
-
(2001)
Diabetes
, vol.50
, Issue.SUPPL. 2
-
-
Hansotia, T.1
Yusta, B.2
Drucker, D.J.3
-
14
-
-
0027533758
-
Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man
-
Wettergren, A., Schjoldager, B., Mortensen, P.E., Myhre, J., Christiansen, J., and Holst, J.J., 1993, Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci 38: 665-673
-
(1993)
Dig Dis Sci
, vol.38
, pp. 665-673
-
-
Wettergren, A.1
Schjoldager, B.2
Mortensen, P.E.3
Myhre, J.4
Christiansen, J.5
Holst, J.J.6
-
15
-
-
0034011021
-
The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans
-
Flint, A., Raben, A., Rehfeld, J.F., Holst, J.J., and Astrup, A., 2000, The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans. Int J Obes Relat Metab Disord 24: 288-298
-
(2000)
Int J Obes Relat Metab Disord
, vol.24
, pp. 288-298
-
-
Flint, A.1
Raben, A.2
Rehfeld, J.F.3
Holst, J.J.4
Astrup, A.5
-
16
-
-
0035432607
-
Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment
-
Larsen, J., Hylleberg, B., Ng, K., and Damsbo, P., 2001, Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtain acceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment. Diabetes Care 24: 1416-1421
-
(2001)
Diabetes Care
, vol.24
, pp. 1416-1421
-
-
Larsen, J.1
Hylleberg, B.2
Ng, K.3
Damsbo, P.4
-
17
-
-
0027248866
-
Normalization of fasting hyperglycemia by exogenous GLP-1 (7-36amide) in type 2 diabetic patients
-
Nauck, M.A., Kleine, N., Ørskov, C., Holst, J.J., Willms, B., and Creutzfeldt, W., 1993, Normalization of fasting hyperglycemia by exogenous GLP-1 (7-36amide) in type 2 diabetic patients. Diabetologia 36: 741-744
-
(1993)
Diabetologia
, vol.36
, pp. 741-744
-
-
Nauck, M.A.1
Kleine, N.2
Ørskov, C.3
Holst, J.J.4
Willms, B.5
Creutzfeldt, W.6
-
18
-
-
0029907680
-
Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide] in patients with NIDDM
-
Nauck, M.A., Wollschläger, D., Werner, J., Holst, J.J., Ørskov, C., Creutzfeldt, W., and Willms, B., 1996, Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide] in patients with NIDDM. Diabetologia 39: 1546-1553
-
(1996)
Diabetologia
, vol.39
, pp. 1546-1553
-
-
Nauck, M.A.1
Wollschläger, D.2
Werner, J.3
Holst, J.J.4
Ørskov, C.5
Creutzfeldt, W.6
Willms, B.7
-
19
-
-
0031033531
-
Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM
-
Rachman, J., Barrow, B.A., Levy, J.C., and Turner, R.C., 1997, Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM. Diabetologia 40: 205-211
-
(1997)
Diabetologia
, vol.40
, pp. 205-211
-
-
Rachman, J.1
Barrow, B.A.2
Levy, J.C.3
Turner, R.C.4
-
20
-
-
0029857454
-
The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients
-
Juntti-Berggren, L., Pigon, J., Karpe, F., Hamsten, A., Gutniak, M., Vignati, L., and Efendic, S., 1996, The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients. Diabetes Care 19: 1200-1206
-
(1996)
Diabetes Care
, vol.19
, pp. 1200-1206
-
-
Juntti-Berggren, L.1
Pigon, J.2
Karpe, F.3
Hamsten, A.4
Gutniak, M.5
Vignati, L.6
Efendic, S.7
-
21
-
-
0037045845
-
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: A parallel-group study
-
Zander M, Madsbad S, Madsen JL, Holst JJ., 2002, Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 359: 824-830
-
(2002)
Lancet
, vol.359
, pp. 824-830
-
-
Zander, M.1
Madsbad, S.2
Madsen, J.L.3
Holst, J.J.4
-
22
-
-
0029797540
-
Glucagon-like peptide-1 undergoes differential tissue-specific metabolism in the anesthetized pig
-
Deacon, C.F., Pridal, L., Klarskov, L., Olesen, M, and Holst, J.J., 1996, Glucagon-like peptide-1 undergoes differential tissue-specific metabolism in the anesthetized pig. Am J Physiol 271: E458-E464
-
(1996)
Am J Physiol
, vol.271
-
-
Deacon, C.F.1
Pridal, L.2
Klarskov, L.3
Olesen, M.4
Holst, J.J.5
-
23
-
-
0027157849
-
Biological effects and metabolic rates of glucagonlike peptide- 1 7-36 amide and glucagonlike peptide- 1 7-37 in healthy subjects are indistinguishable
-
Ørskov, C., wettergren, A., and Holst, J.J., 1993, Biological effects and metabolic rates of glucagonlike peptide- 1 7-36 amide and glucagonlike peptide- 1 7-37 in healthy subjects are indistinguishable. Diabetes 42: 658-661
-
(1993)
Diabetes
, vol.42
, pp. 658-661
-
-
Ørskov, C.1
Wettergren, A.2
Holst, J.J.3
-
24
-
-
0029118049
-
Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV
-
Kieffer, T.J., McIntosh, C.H., and Pederson, R.A., 1995, Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Endocrinology 136: 3585-3596
-
(1995)
Endocrinology
, vol.136
, pp. 3585-3596
-
-
Kieffer, T.J.1
McIntosh, C.H.2
Pederson, R.A.3
-
25
-
-
0002130372
-
Analysis of the degradation of insulinotropin [GLP-1 (7-37)] in human plasma and production of degradation resistant analogs
-
abstract
-
Buckley, D.I., and Lundquist, P., 1992, Analysis of the degradation of insulinotropin [GLP-1 (7-37)] in human plasma and production of degradation resistant analogs. Regul Pept 40: 117 (abstract)
-
(1992)
Regul Pept
, vol.40
, pp. 117
-
-
Buckley, D.I.1
Lundquist, P.2
-
26
-
-
0027215348
-
Dipeptidyl peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1 (7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum
-
Mentlein, R., Gallwitz, B. and Schmidt, W.E., 1993, Dipeptidyl peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1 (7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. Eur. J. Biochem. 214: 829-835
-
(1993)
Eur J Biochem
, vol.214
, pp. 829-835
-
-
Mentlein, R.1
Gallwitz, B.2
Schmidt, W.E.3
-
27
-
-
0033619675
-
Dipeptidyl-peptidase IV (CD26) - Role in the inactivation of regulatory peptides
-
Mentlein, R., 1999, Dipeptidyl-peptidase IV (CD26) - role in the inactivation of regulatory peptides. Regul Pept. 85: 9-24
-
(1999)
Regul Pept
, vol.85
, pp. 9-24
-
-
Mentlein, R.1
-
28
-
-
0036081143
-
GLP-1 (9-36)amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion
-
Deacon, C.F., Plamboeck, A., Møller, S., and Holst, J.J., 2002a, GLP-1 (9-36)amide reduces blood glucose in anesthetized pigs by a mechanism that does not involve insulin secretion. Am J Physiol 282: E873-E879
-
(2002)
Am J Physiol
, vol.282
-
-
Deacon, C.F.1
Plamboeck, A.2
Møller, S.3
Holst, J.J.4
-
29
-
-
0028953577
-
Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide which is a major endogenous metabolite in vivo
-
Deacon, C.F., Johnsen, A.H., and Holst, J.J., 1995, Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide which is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 80: 952-957
-
(1995)
J Clin Endocrinol Metab
, vol.80
, pp. 952-957
-
-
Deacon, C.F.1
Johnsen, A.H.2
Holst, J.J.3
-
31
-
-
0029111540
-
Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides
-
Hupe-Sodmann, K., McGregor, G.P., Bridenbaugh, R., Göke, R., Göke, B., Thole, H., Zimmermann, B., and Voigt, K., 1995, Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1(7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides. Regul Pept. 58: 149-156.
-
(1995)
Regul Pept
, vol.58
, pp. 149-156
-
-
Hupe-Sodmann, K.1
McGregor, G.P.2
Bridenbaugh, R.3
Göke, R.4
Göke, B.5
Thole, H.6
Zimmermann, B.7
Voigt, K.8
-
32
-
-
0030758090
-
Endoproteolysis of glucagon-like peptide (GLP)-1 (7-36) amide by ectopeptidases in RINm5F cells
-
Hupe-Sodmann, K., Göke, R., Göke, B., Thole, H.H., Zimmermann, B., Voigt, K., and McGregor, G.P., 1997, Endoproteolysis of glucagon-like peptide (GLP)-1 (7-36) amide by ectopeptidases in RINm5F cells. Peptides 18: 625-632.
-
(1997)
Peptides
, vol.18
, pp. 625-632
-
-
Hupe-Sodmann, K.1
Göke, R.2
Göke, B.3
Thole, H.H.4
Zimmermann, B.5
Voigt, K.6
McGregor, G.P.7
-
33
-
-
0021853198
-
An immunoradiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissues
-
Gee, N.S., Bowes, M.A., Buck, P., and Kenny, A.J., 1985, An immunoradiometric assay for endopeptidase-24.11 shows it to be a widely distributed enzyme in pig tissues. Biochem J 228: 119-126
-
(1985)
Biochem J
, vol.228
, pp. 119-126
-
-
Gee, N.S.1
Bowes, M.A.2
Buck, P.3
Kenny, A.J.4
-
34
-
-
0034612348
-
Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26
-
Marguet, D., Baggio, L., Kobayashi, T., Bernard, A.M., Pierres, M., Nielsen, P.F., Ribel, U., Watanabe, T., Drucker, D.J., and Wagtmann, N., 2000, Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. Proc Natl Acad Sci U S A 97:6874-6879
-
(2000)
Proc Natl Acad Sci U S A
, vol.97
, pp. 6874-6879
-
-
Marguet, D.1
Baggio, L.2
Kobayashi, T.3
Bernard, A.M.4
Pierres, M.5
Nielsen, P.F.6
Ribel, U.7
Watanabe, T.8
Drucker, D.J.9
Wagtmann, N.10
-
35
-
-
0038200220
-
-
Verfahren zur Herstellung neuer Inhibitoren der Dipeptidyl Peptidase IV. German Patent Application Number DD 296 075 A5
-
Neubert, K., Born, I., Faust, J., Heins, J., Barth, A., Demuth, H.U., Rahfeld, J.U., and Steinmetzer, T., 1983, Verfahren zur Herstellung neuer Inhibitoren der Dipeptidyl Peptidase IV. German Patent Application Number DD 296 075 A5
-
(1983)
-
-
Neubert, K.1
Born, I.2
Faust, J.3
Heins, J.4
Barth, A.5
Demuth, H.U.6
Rahfeld, J.U.7
Steinmetzer, T.8
-
36
-
-
0031916924
-
Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide-1 in anesthetized pigs
-
Deacon, C.F., Hughes, T.E., and Holst, J.J., 1998, Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide-1 in anesthetized pigs. Diabetes 47: 764-769
-
(1998)
Diabetes
, vol.47
, pp. 764-769
-
-
Deacon, C.F.1
Hughes, T.E.2
Holst, J.J.3
-
37
-
-
0000135759
-
Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats
-
Balkan, B., Kwasnik, L., Miserendino, R., Holst, J.J., and Li, X., 1999, Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats. Diabetologia 42: 1324-1331
-
(1999)
Diabetologia
, vol.42
, pp. 1324-1331
-
-
Balkan, B.1
Kwasnik, L.2
Miserendino, R.3
Holst, J.J.4
Li, X.5
-
38
-
-
0036188070
-
Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs
-
Deacon, C.F., Wamberg, S., Bie, P., Hughes, T.E., and Holst, J.J., 2002b, Preservation of active incretin hormones by inhibition of dipeptidyl peptidase IV suppresses meal-induced incretin secretion in dogs. J Endocrinol 172: 355-362
-
(2002)
J Endocrinol
, vol.172
, pp. 355-362
-
-
Deacon, C.F.1
Wamberg, S.2
Bie, P.3
Hughes, T.E.4
Holst, J.J.5
-
39
-
-
0031870418
-
Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isuleucine thiazolidide
-
Pederson, R.A., White, H.A., Schlenzig D., Pauly, R.P., McIntosh, C.H., and Demuth, H.U., 1998, Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isuleucine thiazolidide. Diabetes 47: 1253-1258
-
(1998)
Diabetes
, vol.47
, pp. 1253-1258
-
-
Pederson, R.A.1
White, H.A.2
Schlenzig, D.3
Pauly, R.P.4
McIntosh, C.H.5
Demuth, H.U.6
-
40
-
-
0036228243
-
Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats
-
Pospisilik, J.A., Stafford, S.G., Demuth, H.U., Brownsey, R., Parkhouse, W., Finegood, D.T., McIntosh, C.H., and Pederson, R.A., 2002, Long-term treatment with the dipeptidyl peptidase IV inhibitor P32/98 causes sustained improvements in glucose tolerance, insulin sensitivity, hyperinsulinemia, and beta-cell glucose responsiveness in VDF (fa/fa) Zucker rats. Diabetes 51: 943-950
-
(2002)
Diabetes
, vol.51
, pp. 943-950
-
-
Pospisilik, J.A.1
Stafford, S.G.2
Demuth, H.U.3
Brownsey, R.4
Parkhouse, W.5
Finegood, D.T.6
McIntosh, C.H.7
Pederson, R.A.8
-
41
-
-
0036312876
-
Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats
-
Sudre, B, Broqua, P., White, R.B., Ashworth, D., Evans, D.M., Haigh, R., Junien, J.L., and Aubert, M.L., 2002, Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats. Diabetes 51: 1461-1469
-
(2002)
Diabetes
, vol.51
, pp. 1461-1469
-
-
Sudre, B.1
Broqua, P.2
White, R.B.3
Ashworth, D.4
Evans, D.M.5
Haigh, R.6
Junien, J.L.7
Aubert, M.L.8
-
42
-
-
0036583164
-
Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes
-
Ahrén, B., Simonsson, E., Larsson, H., Landin-Olsson, M., Torgeirsson, H., Jansson, P.A., Sandqvist, M., Bavenholm, P., Efendic, S., Eriksson, J.W., Dickinson, S., and Holmes, D., 2002, Inhibition of dipeptidyl peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes. Diabetes Care 25: 869-875
-
(2002)
Diabetes Care
, vol.25
, pp. 869-875
-
-
Ahrén, B.1
Simonsson, E.2
Larsson, H.3
Landin-Olsson, M.4
Torgeirsson, H.5
Jansson, P.A.6
Sandqvist, M.7
Bavenholm, P.8
Efendic, S.9
Eriksson, J.W.10
Dickinson, S.11
Holmes, D.12
-
43
-
-
0030845208
-
Formation and kinetics of the active drug candoxatrilat in mouse, rabbit, dog and man following administration of the prodrug candoxatril
-
Kaye, B., Brearley, C.J., Cussans, N.J., Herron, M., Humphrey, M.J., and Mollatt, A.R., 1997, Formation and kinetics of the active drug candoxatrilat in mouse, rabbit, dog and man following administration of the prodrug candoxatril. Xenobiotica 27: 1091-1102
-
(1997)
Xenobiotica
, vol.27
, pp. 1091-1102
-
-
Kaye, B.1
Brearley, C.J.2
Cussans, N.J.3
Herron, M.4
Humphrey, M.J.5
Mollatt, A.R.6
|